Merck - $MRK

Up to half the world's experimental drugs now start in China, say Bloomberg reporters

8 insights: Why Merck's next cornerstone cancer drug was discovered in China, what the 2015 rule change did to generics, and the worry US pharma is…

3 hrs ago • The Scuttlebutt

Bloomberg reporters: 16% of pharma licensing deals involved China in 2022, now half

12 insights: The Merck cancer drug that came out of Sichuan, what the 2015 regulatory overhaul did, and why Washington cannot agree on whether to stop…

Sep 16 • The Scuttlebutt

Eric Lefkofsky: the Merck-Moderna drug is a vaccine built for one patient

5 insights: What the skin-cancer headlines left out, why he says health care is the biggest eventual beneficiary of AI, and what 23 years since the…

Sep 15 • The Scuttlebutt

Moderna's Melanoma Vaccine and the $500,000 Check That Started It: a company down more than 90%, a phase three that worked, and Bancel's "We…

The Merck partnership behind the trial, the COVID pivot that took the cancer program's own equipment, 20% short interest earlier this year, and the FDA…

Aug 29 • The Scuttlebutt

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts